![](/img/cover-not-exists.png)
An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels
Rösner, Thies, Derer, Stefanie, Kellner, Christian, Dechant, Michael, Lohse, Stefan, Vidarsson, Gestur, Peipp, Matthias, Valerius, ThomasVolume:
161
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.12209
Date:
April, 2013
File:
PDF, 339 KB
english, 2013